Evonik has partnered with global antibody expression specialist evitria to offer a ready-to-use transient protein expression kit based on CHO cells for biopharmaceutical research and development.
Contract Pharma is a specialized multimedia information outlet focused on the bio/pharma outsourcing sector, providing comprehensive coverage from drug development through to manufacturing. The publication addresses a broad spectrum of themes including pharmaceuticals, healthcare, alternative medicine, diagnostics, manufacturing technology, and healthtech. It delivers the latest industry news, private sector announcements, press releases, and expert commentary—often citing relevant data to support its analysis.
The primary audience for Contract Pharma includes professionals within the pharmaceutical and biotechnology industries such as executives in outsourcing management, R&D specialists, manufacturers, consultants, and those involved in diagnostics or healthcare technology. Its content is tailored for decision-makers seeking up-to-date insights into trends and best practices across the pharma supply chain.
Coverage is characterized by timely reporting on evolving stories within the sector as well as in-depth features that include perspectives from industry leaders. The platform also highlights significant events and developments that impact both established companies and emerging players in bio/pharma outsourcing.
Contract Pharma distributes its content through multiple channels: online digital platforms for immediate access to news; print editions for more traditional readership; and podcasts catering to audiences who prefer audio content or seek expert interviews on-the-go.
